Providence First Trust
IBB icon

Providence First Trust’s iShares Biotechnology ETF IBB Stock Holding History

Providence First Trust’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$726K Buy
+3,449
New +$692K 0.24% 100
2024
Q2 		– Sell
-9,053
Closed -$1.24M – 99
2024
Q1 		$1.24M Sell
9,053
-500
-5% -$68.3K 0.54% 52
2023
Q4 		$1.3M Sell
9,553
-87
-0.9% -$10.6K 0.64% 45
2023
Q3 		$1.18M Sell
9,640
-3,874
-29% -$493K 0.66% 44
2023
Q2 		$1.72M Sell
13,514
-2,011
-13% -$261K 0.94% 39
2023
Q1 		$2.01M Sell
15,525
-178
-1% -$23.3K 1.15% 31
2022
Q4 		$2.06M Hold
15,703
– – 1.21% 30
2022
Q3 		$1.84M Sell
15,703
-1,015
-6% -$126K 1.12% 35
2022
Q2 		$1.97M Hold
16,718
– – 1.11% 35
2022
Q1 		$2.18M Hold
16,718
– – 1.04% 36
2021
Q4 		$2.55M Hold
16,718
– – 1.15% 32
2021
Q3 		$2.7M Hold
16,718
– – 1.28% 30
2021
Q2 		$2.74M Hold
16,718
– – 1.29% 33
2021
Q1 		$2.52M Buy
+16,718
New +$2.66M 1.24% 31

Other funds holding IBB

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
WestEnd Advisors
WestEnd Advisors Charlotte, North Carolina $4.53B AUM 12.98% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.92% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Albion Financial Group
Albion Financial Group Salt Lake City, Utah $1.77B AUM 14.95% 1-Year Est. Return
Generali Investments CEE
Generali Investments CEE Prague, Czech Republic $2.11B AUM 18.35% 1-Year Est. Return
Horizon Wealth Management
Horizon Wealth Management La Grange, Illinois $794M AUM 25.19% 1-Year Est. Return
Appleton Partners
Appleton Partners Boston, Massachusetts $1.63B AUM 29.96% 1-Year Est. Return

Providence First Trust's IBB Position: Q3 2026 in Review

Providence First Trust opened a new position in iShares Biotechnology ETF (IBB) in Q3 2026: 3,449 shares worth $726K. The stake represents 0.24% of the portfolio and ranks #100 among its holdings. This is a return to the name: Providence First Trust previously reported a position in IBB as recently as Q1 2024.

Providence First Trust first reported a position in IBB in Q1 2021 and has held it in 14 quarters since. The position peaked at $2.74M in Q2 2021. 570 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Providence First Trust held 3,449 shares of iShares Biotechnology ETF worth $726K as of Q3 2026.
  • iShares Biotechnology ETF was a new Providence First Trust position in Q3 2026.
  • iShares Biotechnology ETF made up 0.24% of Providence First Trust's portfolio in Q3 2026, its #100 holding.
  • Providence First Trust first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 14 quarters since.
  • Providence First Trust's iShares Biotechnology ETF position peaked at $2.74M in Q2 2021.
  • 570 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Providence First Trust's 13F filing for Q3 2026, filed 2 Nov 2026.